Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 21 February, Robert MacLaren organised a one-day ophthalmology conference in Kyiv together with Dr Andrii Ruban, President of the Ukrainian Vitreoretinal Society.

The conference was held in the basement of an hotel in central Kyiv and attended by 73 ophthalmologists from all over Ukraine, most of whom have been unable to leave the country since the Russian invasion last year. Professor Robert MacLaren took the opportunity to update them on several new developments in clinical ophthalmology, particularly in genetics and retinal diseases.

The Ukrainian medical staff have shown incredible resilience in such uncertain times.
- Professor Robert MacLaren

The conference was well received and has helped establish future collaborations. Robert also met with the Medical Director of ophthalmology in the Ukrainian Armed Forces to find out more about combat eye injuries and attended a clinic and operating list.

Robert said, 'The Ukrainian medical staff have shown incredible resilience in such uncertain times. Their clinical day is often interrupted by air raid sirens indicating an incoming cruise missile, drone or ballistic missile attack on Kyiv. After waiting in an air raid shelter, they then emerge to continue with their clinical duties as if nothing had happened.

'This one-day conference sought to update them on ophthalmology developments that they might have missed due to the war and Covid. It hopefully reminded them that we have not forgotten about their suffering and that we respect their tremendous courage in the face of adversity.'

Similar stories

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

Two NDCN students join BNA Scholars Programme

The British Neuroscience Association Scholars Programme was launched in 2021 with a view to improving equality, diversity and inclusion in neuroscience.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Bioelectronic implant offers an intelligent therapy to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.

Director of MRC Brain Network Dynamics Unit appointed

From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.